Creative Medical Technology announces $2M share repurchase program

Creative Medical Technology (NASDAQ:CELZ) notifies that its board has approved a share repurchase program, to buyback up to $2 million of its shares of common stock.
"Recent market uncertainty has created opportunities under which we believe the repurchase of shares of our common stock is an attractive use of our capital, particularly given our strong balance sheet," said Timothy Warbington, President and CEO of the Company.
YTD, the stock gains 15.6%; current share repurchase forms 3% of its total current market cap.
Shares of CELZ are up 9.9% in premarket trading on Monday.